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ABSTRACT 
Distinctively different metabolism between tumor cells and normal cells endows tumor tissues unique microenvironment. In this regard, we 
have successfully prepared a sequential catalytic platform based on Au/Pt star for tumor theragnostic. The multifunctional probes consisted in 
a gold/platinum star-shaped core (Au/Pt star) conjugated with a GSH-sensitive disulfide bond (S-S), a targeting ligand (rHSA-FA), a 
near-infrared fluorophore (IR780) and glucose oxidase (GOx). When systemically administered in a xenografted murine model, the probes 
specifically targeted the tumor sites. As the disulfide linker was cleaved by intracellular GSH, the IR780 molecules could be released for 
PTT&PDT and imaging. Subsequently, the Pt nanolayer of the Au/Pt star core and the GOx formed a sequential catalytic system: GOx 
effectively catalyzed intracellular glucose by consuming oxygen to generate H2O2 and enhance the local acidity, and the Pt layer exhibited 
peroxidase-like property to catalyze H2O2 producing toxic ·OH for tumor oxidative damage. Here we demonstrated that our probes 
simultaneously possessed a GSH-sensitive release, real-time imaging ability, and synergetic cancer starving-like therapy/enzyme oxidative 
therapy/PTT/PDT features, which provides a potential strategy for effective tumor theragnostic. 
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1 Introduction 
Cancer, regarded as one of the deadliest diseases worldwide, has 
aroused numerous research attentions in developing effective 
therapy methods [1, 2]. And, traditional cancer therapy modality is 
mostly limited to monotherapy such as clinical operation, 
chemotherapy and radiotherapy, which might also induce 
unfavorable tumor metastasis and cause some pain during the 
therapeutic process due to the complexity and diversity of tumor [3, 
4]. Therefore, it is of crucial significance to develop multimodal 
therapeutic methods to reduce the death rate of cancer. Recently, 
emerging cancer therapy methods including photo-thermal therapy 
(PTT), photodynamic therapy (PDT) and chemotherapy possess 
imaging-guided and light-induced therapy efficacy, which flexibly 
integrate therapy with diagnosis [5, 6]. PTT could transfer 
near-infrared light into heat to induce cancer cell apoptosis when 
using photothermic reagent [7], and PDT refers to reactive oxygen 
species (ROS) generation upon irradiation when employing 
photosensitizers [8, 9]. The ideal photosensitizers should possess 
favorable pharmacokinetics and the perfect photothermic reagent 
could transfer absorbed near-infrared (NIR) light (700-900 nm) 
into heat with high safety. IR780 iodide, NIR dye, with good 
quantum yield, deep tissue penetration and excellent stability, 
would be eminent fluorescence molecules for tumor imaging and 
PTT/PDT therapy [7, 10].  
Besides, designing cancer therapeutic modalities based on unique 
tumor microenvironment (TME) is an outstanding strategy, where 
the cellular metabolism, acidic environment and concentration of 
some biological substance (GSH, H2O2, etc.) are distinctly different 
from those in normal tissues. GSH, a significant nonprotein 
biothiol, plays a vital role in regulating cell growth and 
maintaining redox homeostasis with a 4-fold higher concentration 
in tumor than that in normal cells [11, 12], and the intracellular 


































































concentration of GSH reaches to 100- to 1000- times higher than 
that outside of cell [8, 13]. Therefore, numerous stimuli-responsive 
nanoplatforms towards GSH for controllable drug releasing or 
therapeutic reagent delivery have been designed, which could 
realize favorable cancer therapy efficacy with low adverse effects. 
Glucose oxidase (GOx), naturally endogenous oxidoreductase with 
high biocompatibility and low toxicity, could selectively catalyze 
glucose to generate gluconic acid and hydrogen peroxide (H2O2) in 
the presence of oxygen, which could strategically provide cancer 
therapeutic methods including cancer starving-like therapy by 
consuming glucose, hypoxia-activated therapy due to the 
decrement of oxygen, pH-responsive drug release due to the 
generated gluconic acid, and toxic hydroxyl radicals (·OH) induced 
cancer cell apoptosis which were produced under light irradiation 
or via the reaction between nanozyme and elevated H2O2 [14-17]. 
Integrating GOx with nanozymes, hypoxia-activated fluorescence 
molecules, pH-responsive drug delivery system, GSH-responsive 
system, photothermic reagent or photosensitizers into one 
multifunctional nanoplatform could realize multimodal synergistic 
therapy with superadditive treatment effect, offering alternative 
strategies for cancer diagnosis and therapy [18].  
“Artificial enzymes” or “nanozymes” refer to the nanomaterials 
with intrinsic enzyme-mimic catalytic activity and possess low 
cytotoxicity, robust stability and devisable enzymatic catalysis, 
which could be acted as promising alternatives for nature enzymes 
[3, 19, 20]. Commonly used nanozymes contain metal 
nanoparticles [21-23], semiconducting polymer [24, 25] and 
carbon nanomaterials [26] and so on, and are widely applied in 
biomedical assay and cancer therapy, etc. Interestingly, some 
designed nanozymes show peroxidase-like ability in tumor, which 
could catalyze intratumor H2O2 to produce ·OH, and following 
induce the cancer cells apoptosis or necrosis [27, 28]. In recent 
years, gold (Au)- and platinum (Pt)-based nanomaterials have 
drawn widespread interest due to their good biocompatible, high 
chemical stability, potential nanozyme catalytic activity and 
tunable plasmon properties in the NIR regions [29-31]. Star-shaped 
gold nanoparticles (Austar) show distinctive plasmon band in NIR 
window and high absorption in the NIR region, and are widely 
employed in bioimaging, cancer therapy and clinical assay [32, 33]. 
Pt nanoparticles possess unique peroxidase-mimic catalytic activity, 
which could catalyze the H2O2 to produce toxic ·OH in an acid 
condition [34, 35]. Inspired by the unique features of Au and Pt, 
asteroidal Au/Pt nanostructures (Au/Pt star) has been fabricated 
and possesses outstanding photothermal and peroxidase-like 
properties, providing a potentially applicable and combinational 
strategy for cancer therapy. 
Herein, we firstly fabricated core-shell Au/Pt star enzyme carrier 
system, which possessed photothermal property from Au star core 
and peroxidase-like property from Pt shell. Then, L-Cysteine was 
crosslinked onto Au/Pt star to generate functional groups including 
-COOH and -NH2. After covalently conjugating cystamine 
dihydrochloride and targeted complex rHSA-FA onto surface of 
Au/Pt star in successive via EDC/NHS chemistry, the obtained 
nanocomposites (Au/Pt star@S-S@rHSA-FA) physically 
encapsulated IR780 iodide. Ultimately, endogenous oxidoreductase 
GOx was assembled onto above-acquired nanocomposites via GA 
to successfully construct multifunctional probes (Scheme 1A). As 
the probes were targeted to the gastric cancer tumor, IR780 
molecules encapsulated in rHSA could release when disulfide 
linker was cleaved by intracellular GSH. Then, the synergetic 
catalysis reaction would occur including glucose depletion by GOx 
and H2O2 oxidation by Pt, which could realize cancer starvation 
and ·OH induced cancer cells damage. And, under 808 nm laser 
irradiating, PTT therapy and PDT therapy could be achieved. In 
this work, the successfully prepared multifunctional probes (Au/Pt 
star@S-S@rHSA-FA@IR780@GOx) could multirole as diagnostic 
probe for real-time imaging, photothermal reagent for PTT therapy, 
photosensitizer for PDT therapy, glucose consuming enzyme for 
starvation therapy and peroxidase-mimic ability for oxidative 
therapy (details are demonstrated in Scheme 1B), providing a 
promising strategy for eff ective tumor eradication. 
 
Scheme 1.  (A) Schematic illustration for preparation procedure and (B) 
multifunctional application in vivo of probes. 
2 Experimental 
2.1 Reagents and materials  
Gold chloride trihydrate (HAuCl4·3H2O), silver nitrate (AgNO3), 
L-ascorbic acid (AA), trisodium citrate, N-hydroxysuccinimide 
(NHS), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC), hexadecyltrimethylammonium bromide 
(CTAB), L-Cysteine, cystamine dihydrochloride and human serum 
albumin (HSA, 99.9 %) were all bought from Aladdin Reagent Co., 
Ltd. (Shanghai, China). Chloroplatinic acid hexahydrate 
(H2PtCl6·6H2O, 99.9 %) was obtained from Adamas-beta. Folic 
acid (FA), sodium borohydride (NaBH4), and anhydrous dimethyl 
sulfoxide (DMSO) were bought from Sinopharm Chemical 



































































(DAPI), 2′,7′-dichlorofluorescein diacetate (DCFH-DA), Cell 
Counting Kit (CCK-8), Annexin V-FITC/PI Apoptosis Detection 
Kit and Calcein-AM/PI Double Stain Kit were provided by 
YEASEN Corporation (Shanghai, China). The cells were cultured 
by using Fetal bovine serum (FBS), Dulbecco’s Modified Eagle’s 
Medium (DMEM), Penicilline Streptomycin and Trypsine EDTA 
from Gibco Life Technologies. All chemical reagents employed in 
this work were of analytical grade. The pure water was applied in 
this study (18.2 MΩ, Millipore Co., USA). Moreover, phosphate 
buffered solutions (PBS, 0.1 M) were obtained by using 0.1 M 
Na2HPO4 and 0.1 M KH2PO4. 
2.2 Preparing asteroidal Au/Pt bimetallic nanostructures 
(Au/Pt star).  
The asteroidal Au/Pt bimetallic nanostructures (Au/Pt star) used 
as carriers, photothermal regents and catalysis were prepared by 
two steps: (i) the synthesis of asteroidal Au nanoparticles (Au star) 
and (ii) growth of Pt nanolayer on the surface of Au star. The Au 
star nanoparticles were synthesized according to a previously 
reported method with slight modifications [32]. Firstly, little gold 
nanospheres acted as seeds were generated by the chemical 
reaction of HAuCl4 with trisodium citrate. Briefly, 15 mL 
trisodium citrate solution (1 %) was quickly added into 100 mL 
boiling 1 mM HAuCl4 solution with stirring when the color was 
changed into wine red, indicating the successful generation of gold 
seeds. Subsequently, 400 mL HAuCl4 (0.25 mM) was quickly 
mixed with 4 mL freshly prepared gold seeds, 4 mL HCl (1 M) and 
2 mL silver nitrate (3 mM) in succession under stirring. After that, 
2 mL ascorbic acid (0.1 M) was added into above-obtained reaction 
precursor with stirring for 1 min to synthesize the Au star. To 
further prepare asteroidal Au/Pt bimetallic nanostructures, 400 mL 
Au star solution were firstly mixed with 20 mL CTAB (0.1 M) for 
3 h reaction. Then, the CTAB attached Au star were centrifuged to 
remove impurities (10000 rpm/min, 10 min). Afterward, the 
centrifugation-acquired Au star was washed with deionized water 
for three times and redispersed into 100 mL CTAB solution (1 mM) 
with another 2 h stirring at 27 ℃. Following that, 187.5 μL HPtCl4 
(2 mM) and 300 μL AA (0.1 M) were added into the above Au star 
solution, and the mixture was stirred vigorously at a 27 ℃ water 
bath. Within 12 h reaction, the final products named as Au/Pt star 
were successively centrifuged, washed with water (27 ℃), and 
dissolved into 100 mL PBS for further use.  
2.3 Fabricating Au/Pt star@S-S@rHSA-FA nanocomposites 
The Au/Pt star@S-S@rHSA-FA nanocomposites were fabricated 
by systematical functionalizations (showed in Scheme 1A): (i) 
crosslinking L-Cysteine; (ii) conjugating cystamine 
dihydrochloride; (iii) generation of rHSA-FA composites; (iv) 
functionalizing Au/Pt star with rHSA-FA. Crosslinking L-Cysteine 
on the surface of Au/Pt star. At first, 500 mg L-Cysteine was added 
into the above-acquired Au/Pt star solution, followed by reacting 
for 2 h. Conjugating cystamine dihydrochloride onto L-Cysteine 
modified Au/Pt star. After centrifuged by 10000 rpm/min for 3 
mins, the L-Cysteine-conjugated Au/Pt star was dissolved into 20 
mL PBS (0.1 M, pH 7.4), and then mixed with EDC (86.3 mg), 
NHS (200 mg) and cystamine dihydrochloride (500 mg) to produce 
a GSH-sensitive disulfide linkage (Au/Pt star@S-S). The reaction 
system was stirred in dark at a 27 ℃ water bath for 6 h. As the 
reaction finished, the centrifuged precipitate was washed by PBS 
three times and following resuspended in 20 mL PBS (0.1M, pH 
7.4). Generation of rHSA-FA composites. Target molecule folic 
acid (FA) was firstly activated and purified via our previous works 
to synthesize FA-NHS [36]. Meanwhile, reduced human serum 
albumin (rHSA) was synthesized by mixing freshly prepared 
NaBH4 (1 M, 250 μL) with HSA solution (4 mg/mL, 10 mL) for 2 
h stirring reaction. Afterward, 50 mg freeze-dried FA-NHS was 
added into above-generated rHSA solution with continuously 
stirring for 4 h. The final-synthesized rHSA-FA composites were 
collected by centrifugal ultrafiltration (Millipore, 3 K MWCO) and 
then lyophilized for further use. Functionalizing rHSA-FA. To 
construct rHSA-FA functionalized nanocomposites, 20 mL Au/Pt 
star@S-S solution was mixed with EDC (86.3 mg), NHS (200 mg) 
and rHSA-FA (100 mg) with stirring for 6 h reaction. Lastly, 
rHSA-FA crosslinked Au/Pt star@S-S (Au/Pt star@S-S@rHSA-FA) 
were centrifugated, washed by PBS and freeze-dried for further 
use.      
2.4 Loading IR780 molecules into Au/Pt star@S-S@rHSA-FA 
IR780 molecules were also loaded into Au/Pt star@S-S@rHSA-FA 
by physically encapsulating IR780 iodide into the hydrophobic 
cavity of HSA. In detail, 12.5 mg IR780 firstly was dispersed in 
DMSO, and then mixed with 10 mL above-prepared Au/Pt 
star@S-S@rHSA-FA solution (5 mg/mL) for 6 h stirring at 37 °C. 
Then, the final resultant was centrifuged, washed by PBS for three 
times and redispersed into 5 mL PBS (pH 7.4, 0.1 M). Besides, the 
supernatant solution was collected to monitor unloaded IR780 and 
further calculate IR780 entrapment efficiency (EE) and loading 
rate (LR).  
2.5 Immobilizing GOx onto Au/Pt star@S-S@rHSA-FA and 
Au/Pt star@S-S@rHSA-FA@IR780 
GOx acted as an endogenous oxidoreductase could effectively 
consume glucose in the inner of tumor to produce H2O2 and 
gluconic acid. In this study, we immobilize GOx onto Au/Pt 
star@S-S@rHSA-FA and Au/Pt star@S-S@rHSA-FA@IR780 by 
using glutaraldehyde (GA). In brief, 1 mL GA (50 %) solution was 
respectively added into 10 mL Au/Pt star@S-S@rHSA-FA (5 
mg/mL in PBS) and 10 mL Au/Pt star@S-S@rHSA-FA@IR780 
(6.1 mg/mL in PBS) solution. After 20 min stirring, 1 mL GOx 
solution (6 mg/mL in PBS) was added into the mixture for 6 h 
reaction. Finally, the product was successively centrifuged, washed 
by PBS and redispersed into 10 mL PBS (pH 7.4, 0.1 M) for 
further use. 
The entrapment efficiency (EE) and loading rate (LR) of IR780 
molecules in this study were calculated referring to following 
equations: 
EE (%) = (Weight of IR780 in Au/Pt star @S-S@rHSA-FA@IR780@GOx 
nanoprobes) / (Weight of IR780 added initially) × 100 % 
LR (%) = (Weight of loaded IR780) / (Weight of Au/Pt 
star@S-S@rHSA-FA@IR780@GOx) ×100 % 
2.6 Characterization of different nanomaterials 
The morphological and structural information of various materials 
was investigated by field emission transmission electron 
microscopy (FE-TEM, Talos F200X). The zeta potentials of 
various materials were carried out on a zeta potential/particle sizer 


































































spectrophotometer (Varian Inc., Palo Alto, CA, USA) and Fourier 
transform infrared spectrometer (FTIR, Nicolet 6700) was carried 
out to monitor the assembly process of probes. The fluorescence 
spectrum of different nanomaterials was measured on a 
spectrofluorometer (Hitachi FL-4600). 
2.7 Peroxidase-like enzymatic catalysis property of various 
materials 
The peroxidase-like enzymatic catalysis ability of various 
materials was investigated by recording the UV-Vis absorbance 
peaks of oxidized TMB. Briefly, the nanomaterials including Au/Pt 
star and Au/Pt star@S-S@rHSA-FA were respectively dissolved 
into NaAc buffer (0.1 M, pH 6.0) in presence of TMB (0.416 mM) 
and H2O2 (100 μM). After 10 min reaction, the reaction solution 
was performed on a UV-vis spectrophotometer to show the 
catalysis ability. To further study the effect of pH on the catalysis 
system, 1.0 mL NaAc (0.1 M) buffer solution at various pH (4.5 to 
6.0) was employed to dissolve Au/Pt star in presence of TMB 
(0.416 mM) and H2O2 (100 μM), and the UV-Vis absorbance 
spectra at various time were recorded.   
2.8 Hydroxyl radical ( OH) analysis 
Terephthalic acid (TA) could be used to capture ·OH and 
following produced 2-hydroxy terephthalic acid, which displayed 
an obvious emission fluorescence around 435 nm under 315 nm 
excitation while negligible fluorescence produced by TA. Briefly, 
1.0 mL 0.1 M NaAC buffer in pH 6.0 was applied to dissolve 
various materials. And then, H2O2 (final concentration: 100 μM) or 
glucose (final concentration: 5 mM) was added into the reacted 
system for 30 min or 3 h incubation in respective. After interaction, 
1 mL TA solution (4 mM dissolved into 10 mM NaOH) was mixed 
with above-acquired solution for another 30 min reaction under 
shaking. Ultimately, the obtained solution was testified on a 
fluorescent spectrophotometer. 
2.9 Singlet oxygen investigation 
The singlet oxygen sensor green (SOSG) regent is a useful tool 
for 1O2 detection. In this work, 2.5 μM SOSG was applied to detect 
the generated 1O2 in different systems including free IR780 (acted 
as control) and probes (equivalent 50 μg/mL IR780) with or 
without 5 min 808 nm irradiation. Besides, the systems were 
performed on a fluorescent spectrophotometer (λex: 494 nm) to 
collect SOSG fluorescence.  
2.10 The laser-induced temperature change of probes in vitro 
The 808 nm laser-induced temperature change prolonging with 
the time in PBS (used as control), probes (equivalent IR780 dosage: 
20 μg/mL and 60 μg/mL) groups was monitored by using an 
infrared imaging camera. 
2.11 In Vitro GSH-Responsive Behavior of Au/Pt 
star@S-S@rHSA-FA@IR780 
The responsive behavior of Au/Pt 
star@S-S@rHSA-FA@IR780@GOx toward GSH was investigated 
by measuring fluorescence intensity after IR780 releasing from the 
probes in vitro. In brief, 10 mL Au/Pt 
star@S-S@rHSA-FA@IR780@GOx solution ([IR780]: 50 μg/mL) 
were respectively treated by 0 mM GSH, 10 mM GSH and 50 mM 
GSH, and then the mixture was shaking with 200 rpm/min. At 
various time points, the solution was centrifuged by centrifugal 
ultrfiltration (Amicin Ultr-15, Millipore, 100 K MWCO) and 
following diluted into 10 times. Finally, the solution was 
quantitatively calculated by a fluorescent spectrophotometer.  
The release percentages (RP, w/w %) were calculated as the 
following equation:  
RP_IR780(%) = (Release weight of IR780) / (Initial weight of IR780 in Au/Pt 
star@S-S@rHSA-FA@IR780@GOx) × 100 % 
2.12 Cell culture 
The cell line used here was gastric cancer cells (MGC-803) and 
cultured in DMEM containing fetal bovine serum (v/v=10 %), 
penicillin (100 U/mL) and streptomycin (0.1 mg/mL) at 37 °C with 
5 % CO2 (defined as complete medium). And the MGC-803 cells 
were subcultured by using Trypsin/EDTA. When the cells were in 
the logarithmic growth phase, they were used in this experiment. 
2.13 Cellular Uptake Assay 
For cellular uptake study, microscopy and FC were synergistically 
employed in this study. For qualitatively observe the cellular 
uptake, the cells were firstly cultured in glass coverslips (14 mm) 
for 24 h. Following, free IR780 (3 μg/mL) and probes (18 μg/mL) 
were respectively added and interacted with cells. At various 
periods (1, 4 and 12 h), the cells were washed by PBS, fixed by 
4 % paraformaldehyde for 30 min and stained with DAPI for 5 min 
in dark. After washed by PBS gently, the cells were observed by a 
confocal laser scanning microscopy (CLSM) (DAPI, excitation: 
405 nm and emission: 440 to 470 nm; IR780 in probes, excitation: 
633 nm and emission: 700 to 800 nm).    
To quantitatively show the endocytosis towards probes, the cells 
(1×105/well) were cultured in a 6-well plate for 24 h, and then the 
cells were interacted with free IR780 (3 μg/mL) and probes (18 
μg/mL) for 1, 4 and 12 h. Then, the cells were collected by using 
trypsin. After washed by PBS, the cells were resuspended into 1.5 
mL PBS for FC assay. The signal in FL3-H channel was monitored 
to study endocytosis of probes. 
2.14 Cytotoxicity study of various materials 
Cytotoxicity investigation was of crucial importance in evaluating 
the biocompatibility, safety and therapeutic efficacy of 
final-obtained probes. In this work, CCK-8 Assays, Apoptosis 
Assay and Calcein-AM/PI Staining Assay were synchronously 
utilized to assess the dark toxicity and phototoxicity of probes to 
cells.  
CCK-8 experiment. In detail, MGC-803 cells (5×103 per well) 
were firstly cultured in 96-cell plates for 24 h. Then, the culture 
medium of cells was replaced by 100 μL complete medium in low 
glucose containing PBS, IR780, Au/Pt star@S-S@rHSA-FA@GOx 
or Au/Pt star@S-S@rHSA-FA@IR780@GOx at various 
concentrations range: 0.25 - 3 μg/mL of IR780 and 1.25 - 15 
μg/mL of Au/Pt star@S-S@rHSA-FA@GOx. After 8 h endocytosis, 
the cells were washed by fresh complete medium and then were 
irradiated with or without 808 nm laser (1.0 W/cm2, 5 min). After 
that, the cells were cultivated for another 8 h. Finally, the cells’ 


































































investigated on a Microplate Reader by using a 450 nm absorbance. 
The cell viability was studied via formula:       
Cell viability = (ODExperimental group - ODBlank) / (ODControl -ODBlank)  100 % 
Apoptosis Assay. The apoptosis situation of cells in various 
experimental groups was performed on a BD FACSCalibur, where 
the Annexin V-FITC/PI Apoptosis Detection Kit (Yeasen, Shanghai) 
was carried out to stain cells. Briefly, MGC-803 cells were firstly 
seeded into a 6-cell plate with a density of 1 × 105 cells per well for 
24 h and then replaced by complete medium in low glucose 
contained PBS, IR780, Au/Pt star@S-S@rHSA-FA@GOx and 
probes (IR780: 3 μg/mL, Au/Pt star@S-S@rHSA-FA@GOx: 15 
μg/mL) for 8 h incubation. After washed with fresh complete 
medium and irradiated with or without 808 nm laser (1.0 W/cm2, 5 
min), the cells were incubated in dark for another 8 h. Following 
that, the cells were collected and dyed by Annexin V (5 μL) and PI 
(10 μL) in dark for 20 min. Finally, the dyed cells were analyzed 
on flow cytometry (FC) and the recorded data were investigated by 
FlowJo 10.0 software.         
Calcein-AM and PI Staining Assay. To observe the live/dead 
situation of MGC-803 cells after interacted with probes by 
naked eye, the probes treated cells were stained by calcein-AM and 
PI and subsequently observed on a fluorescence microscope. In 
brief, the cells (1.0 × 104 cells/well) were incubated in 6-cell plates 
for 24 h. Then, the cells were treated with probes (18 μg/mL) and 
sustained 8 h incubation. Following washed and replaced by fresh 
medium, the cells were treated with or without irradiation. After 12 
h incubation in dark, the cells were stained by calcein-AM (2.0 μM) 
and PI (1.5 μM) for 15 min at 37 ℃. Ultimately, after washed by 
PBS, the cells were imaged at a fluorescence microscope. 
2.15 Animals and tumor model 
The female nude mice (5 weeks’ old, 15~18 g) were all provided 
by Shanghai Jiesijie Laboratory Animal Co. Ltd. (China). And all 
mice were raised referring to the guidelines of Approval of 
institutional Animal Care and Use Committee of Shanghai Jiao 
Tong University. To establish tumor model, MGC-803 cells (4 × 
106 cells in 100 μL complete medium) were injected into right leg 
of mice. As the tumor size was near to 100 mm3, the mice were 
used for experiment. 
2.16 In vivo and ex vivo fluorescence imaging 
To real-time investigate the targeted efficacy of prepared probes 
(Au/Pt star@S-S@rHSA-FA@GOx@IR780), NIR fluorescence 
imaging of mice at various time points was observed and imaged 
by a imaging system (Bruker In-Vivo F PRO, Billerica, MA, USA), 
where the parameters were set up as followed: excitation at 720/20 
nm, emission at 790/30 nm, exposure time in 60 s. Briefly, 100 μL 
of free IR780 and probes (equivalent IR780 concentration: 5 mg/kg) 
were intravenously injected into the tumor-bearing mice. Then, the 
time-course fluorescence images of tumor were recorded from 2 to 
60 h.  
Additionally, the mice treated by IR780 and probes were 
sacrificed at 48 h and the tissues (heart, liver, spleen, lung, kidney 
and tumor) were imaged with the same parameters as mentioned 
above. Moreover, the fluorescence intensity of various tissues was 
recorded by a Bruker Molecular Imaging Software. 
2.17 In vivo synergistic therapy 
To evaluate the therapy efficacy of probes, the tumor-bearing 
mice were intravenously treated with 100 μL of PBS (control 
group), free IR780, Au/Pt star@S-S@rHSA-FA@GOx and 
Probes(equivalent IR780 concentration: 5 mg/kg and equivalent 
Au/Pt star@S-S@rHSA-FA@GOx concentration: 25 mg/kg) 
respectively. After 36 h post-injection, the tumor in various groups 
was irradiated by 808 nm laser (1.0 W/cm2, 5 min). Meanwhile, 
infrared camera was employed to record the temperature 
fluctuation in tumor sites and infrared pictures of mice. Besides, 
the relative tumor size and body weight were monitored every 
three days within 15 days. Moreover, the information of tumors in 
different experimental groups was also monitored every three days 
within 15 days by a camera. After 15 days’ experiment, the main 
organs in PBS and probes treated mice were excised, dyed with 
hematoxylin and eosin (H&E), and further studied morphological 
features of each group.  
2.18 Statistical Analysis 
All results described in this work were showed as means ± SD. 
3 Results and discussion 
3.1 Characterization of various materials 
The synthesis process of probes was presented in Scheme 1A. To 
testify the successful preparation of enzyme carrier system Au/Pt 
star, the morphologies and structural information of Au star and 
Au/Pt star were investigated by a high-resolution transmission 
electron microscopy (HR-TEM). As illustrated in Fig. 1A, the 
asteroidal structure of Au star could be observed, endowing 
excellent growth platform for Pt nanoparticles. As observed in Fig. 
1B, the morphological structure and size of the Au/Pt star were 
similar to that of Au star, showing star-like shape with a uniformly 
average size of ca. 75 nm according to the size distribution in Fig. 
S1 Moreover, as shown in the enlarged TEM picture of Au/Pt star 
(Fig. 1C), a rough structure could be observed on the surface of Au 
star, suggesting the successful formation of Pt nanoparticles based 




































































Fig. 1. HR-TEM images of (A) Au star and (B) Au/Pt star. (C) enlarged TEM 
picture of Au/Pt star. (D) BF-STEM and (E) HAADF-STEM pictures of Au/Pt 
star. (F-H) The EDX elemental mapping images of Au/Pt star. (I) 
energy-dispersive X-ray spectroscopy of Au/Pt star. 
And the BF-STEM (Fig. 1D) and HAADF-STEM (Fig. 1E) 
pictures of Au/Pt star further validated the star-like structure of 
Au/Pt bimetallic carrier. Additionally, the energy-dispersive X-ray 
spectroscopy (EDX) elemental mapping clearly presented the 
distribution of Au and Pt atoms in Au/Pt bimetallic nanostructures 
(Fig. 1F- H), showing an asteroidal Au core and star-like Pt shell 
in the Au/Pt star. From energy-dispersive X-ray spectroscopy (Fig. 
1I), the mass ratio of Pt/Au in Au/Pt star carrier could be 
approximately calculated as 1/7.    
To monitor the successful modification of the probes, the 
systematic change of the nanomaterials was monitored by UV-vis 
spectroscopy, Fourier Transform infrared spectrum (FTIR) and zeta 
potential measurement. As showed in the UV-vis measurement 
(Fig. 2A), the obtained gold nanoparticles displayed a specific 
peak at 520 nm (curve a). When the Au star was produced by using 
Au NPs, there was a specific LSPR peak around 800 nm (curve b), 
indicating the successful generation of Au star core. Followingly 
generating a layer of Pt shell, there was still an obvious LSPR peak 
around 800 nm, indicating the reservation of star-like structure in 
the nanoparticles (curve c). After functionalizing a targeted 
complex rHSA-FA on the surface of Au/Pt star, there were typical 
absorption peak at 800 nm due to the existence of Au/Pt star and 
additional absorption peaks at 280 nm and 346 nm which were 
corresponded to the absorption of rHSA and FA respectively, 
revealing the successful crosslinking of rHSA-FA (curve d). When 
GOx was covalently crosslinked with rHSA-FA (curve e), there 
was more obvious 280 nm peak due to GOx and rHSA, 346 nm 
corresponding to FA and 800 nm owing to Au/Pt star. From the 
curve f in Fig. 2A, we could conclude that the fluorescence 
molecules IR780 showed a typical UV-vis absorption peak at 775 
nm. As the IR780 molecules have been loaded into the probes, 
there was a specific peak around 600 to 900 nm (curve g) with a 
red-shifted from 775 to 823 nm due to the accumulation of IR780, 
proving the successful encapsulation of IR780 into probes finally. 
FTIR could provide accurate surficial information of 
nanomaterials. As shown in Fig. 2B, CTAB modified Au/Pt star 
(curve a) exhibited the same specific peaks at 2918 cm-1 and 1467 
cm−1 as pure CTAB from the reported reference [37], which was 
attributed to the asymmetric stretching vibrations of C–CH2 and 
the deformation of –CH2– and –CH3. When the L-cysteine was 
attached to Au/Pt star (curve b), there were specific peaks at 
3449 cm−1 and 1630 cm−1 due to the formation of -NH2 and 
-COOH. Compared with the IR peaks in free cystamine in Fig. S2, 
new specific peak showed in 1638 cm-1 as the cystamine was 
crosslinked onto Au/Pt star@L-cys via EDC/NHS (curve c), 
indicating the successful generation of amido linkage between 
L-cysteine and Cystamine. In addition, a specific peak at 1638 cm-1 
in curve d respectively relying on the generation of ester bond 
between rHSA-FA and Cystamine, and the peak at 1400 cm-1 was 
owing to the vibration of benzene ring in FA. Additionally, there 
was an obvious ester bond peak at 1638 cm-1(curve e). Compared 
with curve e, as the IR780 molecules were loaded into Au/Pt 
star@S-S@rHSA-FA@IR780@GOx, there were additional 1555, 
1400, 1371, and 1252 cm-1 due to the stretching vibration of C=C 
in IR780 (Fig. S2), indicating the successfully loading of IR780 
into Au/Pt star@S-S@rHSA-FA@IR780@GOx. Moreover, the 
corresponding FTIR information of IR780 was displayed in curve 
d of Fig. S2.  
In zeta potential measurement, we could clearly find the surface 
change during the fabrication process. As demonstrated in Fig 2C, 
the CTAB attached Au/Pt star exhibited a positive potential at 
29.38 mV, which was due to electropositivity of CTAB molecules. 
As the L-cysteine was crosslinked onto the Au/Pt star, the potential 
of Au/Pt star@L-cys changed into a negative potential at -5.47, 
indicating the successfully assembling of L-cysteine. When the 
Cystamine molecules were crosslinked with Au/Pt star@L-cys by 
EDC/NHS chemistry (abbreviated as Au/Pt 
star@L-cys@Cystamine), there was an obvious positive potential 
appeared at 15.73 mV owing to the existence of terminal -NH2 
groups in cystamine. After the rHSA-FA was attached onto the 
Au/Pt star@L-cys@Cystamine, the electronegative rHSA changed 
the potential into -15.28 mV. As the IR780 molecules were loaded 
into Au/Pt star@L-cys@Cystamine@rHSA-FA, the potential has 
shifted to - 6.17 mV, suggesting the successful assemble of IR780. 
Finally, when the GOx was crosslinked to the Au/Pt 
star@L-cys@Cystamine@rHSA-FA@IR780, the potential 
decreased to   -12.03 mV due to the electronegative protein 
property of GOx (abbreviated as Au/Pt 
star@S-S@rHSA-FA@IR780@GOx). All above-mentioned 
potential results proved the systemically successful preparation of 
probes Au/Pt star@S-S@rHSA-FA@IR780@GOx. In addition, 
according to calibration curve between UV-vis absorbance 
intensity and IR780 concentrations (Fig. S3), the EE and LR of 
IR780 could be calculated into 88 % and 16.67 % in respective. 
 
Fig. 2. Characterization of various materials: (A) UV−vis absorption spectra 
of Au NPs (a), Au star (b), Au/Pt star (c), Au/Pt star@S-S@rHSA-FA (d), 
Au/Pt star@S-S@rHSA-FA@GOx (e), IR780 (f), Au/Pt 
star@S-S@rHSA-FA@IR780@GOx (g). (B) FTIR spectra of various 
materials from a to f: Au/Pt star, Au/Pt star@L-cys, Au/Pt 
star@L-cys@Cystamine, Au/Pt star@L-cys@Cystamine@rHSA-FA, Au/Pt 
star@L-cys@Cystamine@rHSA-FA@GOx and Au/Pt 
star@S-S@rHSA-FA@IR780@GOx. (C) Zeta potentials of Au/Pt star (I), 
Au/Pt star@L-cys (II), Au/Pt star@L-cys@Cystamine (III), Au/Pt 
star@L-cys@Cystamine@rHSA-FA (IV), Au/Pt 
star@L-cys@Cystamine@rHSA-FA@IR780 (V) and Au/Pt 
star@S-S@rHSA-FA@IR780@GOx (VI). (D) UV−vis absorption spectra of 


































































(b) TMB in presence of H2O2 and Au/Pt star, (c) TMB in presence of H2O2 and 
Au/Pt star@S-S@rHSA-FA in NaAc buffer (pH 6.0). Inset: UV−vis 
absorbance fluctuation of Au/Pt star@S-S@rHSA-FA at 652 nm in various pH 
value (4.5-6.0). Parameters: [TMB]: 0.416 mM, [H2O2]: 100 μM, [equivalent 
Au/Pt star]: 50 μg/mL. 
3.2 Mimicking Enzymatic Activities 
The peroxidase-like property of Au/Pt star and Au/Pt 
star@S-S@rHSA-FA have been studied by oxidizing the 
tetramethylbenzidine (TMB) in the presence of H2O2, which would 
show a maximum absorbance at 652 nm. As showed in Fig. 2D, no 
obvious 652 nm absorption peak showed in curve a (control group), 
while the Au/Pt star and Au/Pt star@S-S@rHSA-FA groups 
displayed specific absorption peak at 652 nm and the intensities 
were almost the same (curve b and c), indicating favorable 
catalytic capacity of Au/Pt star even though modifying a biolayer 
on its surface. Moreover, the absorbance fluctuation of Au/Pt 
star@S-S@rHSA-FA at 652 nm in various pH value (4.5-6.0) 
prolonging with time were exhibited in the inset of Fig. 2D, and it 
could conclude that the acidic environment improved the 
peroxidase-like catalysis ability of Au/Pt star.  
Besides, the fluorescence of 2-hydroxy terephthalic acid collected 
from Au/Pt star@S-S@rHSA-FA, Au/Pt 
star@S-S@rHSA-FA@GOx and probes were almost same and 
much stronger than control group, which was attributed to that 
peroxidase-like Au/Pt star could catalyze H2O2 to generate ·OH 
and the obtained ·OH could followingly react with HA to produce 
2-hydroxy terephthalic acid (Fig. 3A). To further show the 
catalysis ability of GOx in probes toward glucose, various 
materials including Au/Pt star@S-S@rHSA-FA, Au/Pt 
star@S-S@rHSA-FA@GOx and probes were carried out to reacted 
with 5 mM glucose and HA. As displayed in Fig. 3B, the 
fluorescence signals of 2-hydroxy terephthalic acid in Au/Pt 
star@S-S@rHSA-FA@GOx and probes groups were much 
stronger than that in Au/Pt star@S-S@rHSA-FA, which was due to 
that GOx could firstly catalyze glucose to generate hydrogen 
peroxide (H2O2) and the obtained H2O2 could be further reacted 
with Au/Pt star to produce ·OH for 2-hydroxy terephthalic acid 
generation. However, a relatively moderate fluorescence signal of 
2-hydroxy terephthalic acid could be observed in Au/Pt 
star@S-S@rHSA-FA group, which might be attributed to potential 
enzymatic ability of Pt nanomaterials toward glucose as reported 
references [38, 39]. In addition, the control group showed no 
fluorescence intensity, proving that glucose could not produce ·OH. 
All results indicated that surficial GOx in probes could effectively 
increase H2O2 concentration by catalyzing glucose and the inner 
Au/Pt star possessed excellent peroxidase-like ability to 
generate ·OH in presence of H2O2, which could perform 
glucose-consuming induced starvation therapy and ·OH caused 
oxidative therapy for cancer. 
3.3 PDT and PTT study of probes in vitro 
IR780, NIR-absorbing fluorescent reagent, could be utilized for 
photodynamic reagent and photothermic reagent for tumor therapy 
under 808 nm laser irradiation. To study the PDT effect of probes 
(the generation of singlet oxygen), the SOSG reagent in 2.5 ×10-6 
M was carried out to monitor the production of singlet oxygen. As 
showed in Fig. 3C, there was negligible SOSG fluorescence 
observed in free IR780 and probes (Au/Pt 
star@S-S@rHSA-FA@IR780@GOx) without 808 nm irradiation. 
However, when the systems were irradiated under 808 nm laser 
(1.0 W/cm2, 5 min), distinct fluorescence signals could be captured 
in both free IR780 and probes groups, indicating outstanding 
singlet oxygen generation of IR780 in probes when given 808 nm 
laser irradiation. 
To testify the photothermal efficiency of final-acquired probes 
(Au/Pt star@S-S@rHSA-FA@IR780@GOx), the temperature 
fluctuations prolonging with time at different concentrations have 
been investigated under 808 nm laser (1.0 W/cm2) irradiation. As 
showed in Fig. 3D, the control group (PBS) exhibited a mild 
temperature increment, while the probes (20 and 60 μg/mL of 
IR780) showed high temperature increasing from 22 to 41 and 22 
to 54 °C respectively. The obvious temperature change in probes 
might be caused by the synergistically photothermal conversion 
ability from Au/Pt star and IR780, suggesting eminent heat 
generation and the irreversible PTT therapeutic ability of probes.  
 
Fig. 3. ·OH detection in various systems: (A) fluorescence spectra of H2O2 + 
TA (control), H2O2 + Au/Pt star@S-S@rHSA-FA + TA, H2O2 + Au/Pt 
star@S-S@rHSA-FA@GOx + TA and H2O2 + Au/Pt 
star@S-S@rHSA-FA@IR780@GOx + TA. (B) fluorescence spectra of glucose 
+ TA (control), glucose + Au/Pt star@S-S@rHSA-FA + TA, glucose + Au/Pt 
star@S-S@rHSA-FA@GOx + TA and glucose + Au/Pt 
star@S-S@rHSA-FA@IR780@GOx + TA. Parameters: [H2O2]: 100 μM, 
[Au/Pt star@S-S@rHSA-FA]: 50 μg/mL, [Au/Pt star@S-S@rHSA-FA@GOx]: 
55 μg/mL, [Au/Pt star@S-S@rHSA-FA@IR780@GOx]: 66 μg/mL, [glucose]: 
5 mM. (C) Fluorescence curves of SOSG for singlet oxygen (1O2) 
determination from free IR780 and probes in absence or presence of laser 
irradiation. (D) Temperature fluctuation of PBS (control) and probes (IR780 
content: 20, 60 μg/mL) under 808 nm laser irradiation (1.0 W/cm2) during 300 s 
(n=3). The inset: photo-thermal pictures after 5 min irradiation. (E) Cumulative 


































































mM) at pH 7.4 within 24 h. (F) Fluorescence curves of IR780 at different 
concentrations (λex: 780 nm). Inset: Calibration curve of IR780 fluorescence 
intensity and concentration. 
3.4 In Vitro GSH-dependent IR780 releasing of Au/Pt 
star@S-S@rHSA-FA@IR780 
The GSH-responsive property of probes was investigated by 
monitoring the fluorescence intensities of released IR780 due to 
the interaction between probes and GSH. As shown in Fig. 3E, 
cumulative release of IR780 from probes reached to 10.3 % (no 
GSH), 64 % (10 mM GSH) and 80.30 % (50 mM GSH) within 24 
h, indicating that our constructed probes presented an 
GSH-dependent IR780 releasing due to the favorable cleavage 
ability toward disulfide linker of probes by GSH. Moreover, the 
amount of released IR780 was calculated according to the 
calibration curve between fluorescence intensity and IR780 
concentrations (shown in Fig. 3F). Here mentioned results 
indicated that our prepared probes demonstrated favorable IR780 
releasing response to GSH, which could enhance probes’ 
therapeutic performance in unique tumor microenvironment. 
3.5 Cellular uptake and intracellular distribution 
The target effect and cellular uptake efficiency at various times 
between cells and materials (free IR780 and probes) were studied 
by synergistically using CLCM and FC (Fig. 4 A-B). As 
demonstrated in Fig. 4A, the fluorescence intensity of IR780 (red 
signal) in both groups were enhanced as the interaction time 
prolonged, suggesting gradual increment of the cellular uptake. 
And, the blue fluorescence signal reflected the location of cell 
nuclei stained by DAPI dye. Comparing the confocal images of 
cells treated with IR780 and probes in respective, we could find 
that the fluorescence signal of IR780 in probes was brighter than 
the free IR780 groups, proving easy endocytosis of the probes by 
cancer cells due to specifically targeted recognition of FA to 
MGA-803 cells.  
To quantitatively study the cellular uptake efficiency of probes, 
the red fluorescence values in cells were calculated by FC. As 
exhibited in Fig. 4B, the signal values were increased with the 
interacted time between the materials and cells, and the intensity 
value of free IR780 and probes were calculated into 292 and 385 in 
respective after 12 h internalization, suggesting that probes could 
be acted as excellent carriers to transport numerous dye IR780 
molecules. All above-discussed results concluded that the 
final-obtained probes presented an efficient cellular uptake, which 
was beneficial for the following in vivo therapy.  
 
Fig. 4.  Cellular uptake analysis. (A) CLSM pictures of cells incubated with 
free IR780 and probes at various times (1, 4, 12 h). Scale bar: 50 μm. (B) 
Quantitative investigation of the cellular uptake efficiency by FC. 
3.6 In vitro photo-induced cell toxicity.  
To superiorly investigate the photo-induced therapy efficacy of 
probes towards the MGC-803 cells, the safe concentration of 
various materials was applied in cell toxicity assay, ensuring the 
favorable biocompatibility and excellent cell viability of various 
materials in dark. Firstly, we evaluated the cellular proliferation 
inhibition of various materials without laser irradiation. As 
demonstrated in the CCK-8 assay (Fig. 5A), we could observed 
that the experimental groups including free IR780, Au/Pt 
star@S-S@rHSA-FA@GOx and probes ([IR780]: 0.25-3 μg/mL, 
[Au/Pt star@S-S@rHSA-FA@GOx]: 1.25-15 μg/mL) exhibited 
great biocompatibility towards cells in dark. However, when given 
the 808 nm laser irradiation, the survival rate of cells showed an 
obvious decrement upon the increasing of concentrations in free 
IR780, Au/Pt star@S-S@rHSA-FA@GOx and probes groups. 
Typically, compared with free IR780 or Au/Pt 
star@S-S@rHSA-FA@GOx group, the cell viability of probes 
group in presence of laser irradiation was much lower and reached 
to 35 % when the concentration of probes were at 18 μg/mL, 
meanwhile the concentration of IR780 was at 3 μg/mL and Au/Pt 
star@S-S@rHSA-FA@GOx was at 15 μg/mL, indicating that here 
constructed probes performed an outstanding photo-induced 
therapy effect. The favorable photo-induced therapy in probes 
group might be attributed to the synergistic PTT therapy of IR780 
and Au/Pt star@S-S@rHSA-FA, the PDT therapy of IR780 as well 
as the favorable targeting ability of the FA in probes. 
  Meantime, the FC was carried out to investigate the survival rate 
of cells after interacted with PBS, free IR780 (3 μg/mL), Au/Pt 
star@S-S@rHSA-FA@GOx (15 μg/mL) and probes (12 μg/mL) 
with or without 808 nm laser irradiation for 5 min. And, the cells 
were dually labeled by Annexin V-FITC and propidium iodide (PI). 
As showed in Fig. 5B, no obvious cell apoptosis appeared in the 
PBS group in dark or irradiation, indicating the relative safety of 
laser power to cells. In addition, the cells interacted free IR780 (3 
μg/mL), Au/Pt star@S-S@rHSA-FA@GOx (15 μg/mL) and probes 
(18 μg/mL) in dark showed no change in cell apoptosis. However, 
after 808 nm laser irradiating, the cells incubated with free IR780 


































































probes (18 μg/mL) presented cell apoptosis, and the cells in probes 
groups were at the highest death rate. 
For visually observing the therapy effect of probes upon the laser 
irradiation, Calcein-AM and PI staining method was used to 
analyze the cell viability. Herein, red fluorescence of PI revealed 
dead cells while green fluorescence of calcine AM shown live cells. 
As exhibited in Fig. 5C, there was almost no red fluorescence 
signal showed in the cells incubated with probes (18 μg/mL) in 
dark, indicating no obvious dead cells generated without irradiating. 
In contrast, the strong red fluorescence signal showed in the cells 
after 808 nm laser irradiation, proving visual cells death appeared 
after irradiation and remarkable therapeutic efficacy of here 
constructed probes. The results acquired here totally reconfirmed 
the CCK-8 assay and FC measurement above. 
 
Fig. 5. Cell toxicity assay: (A) CCK-8 assay (n=5), (B) FC study and (C) 
Calcein-AM and PI staining measurement (Scale bar: 200 μm) for investigation 
of dark toxicity and photo toxicity.  
3.7 Cellular ROS analysis 
When Au/Pt star@S-S@rHSA-FA@IR780@GOx were ingested 
by cancer cells, the special metabolism of cancer cells and 
GOx-mediated glucose consumption might led to significant 
increment of H2O2 in cells, resulting noninvasive cancer starvation, 
gluconic acid-activated acidity enhancement and toxic hydroxyl 
radical (·OH) induced cells apoptosis based on the reaction 
between Au/Pt star nanoparticles and H2O2. To study the 
cellular ·OH production based on the sequential catalysis reactions 
from GOx and Au/Pt star, the H2DCFDA dye was applied to stain 
cells after the cells were incubated with Au/Pt 
star@S-S@rHSA-FA@GOx (0 to 200 μg/mL) by using complete 
medium in low glucose, and then the stained cells were 
investigated by CLSM and FC. As shown in confocal images of 
Fig. 6A, the green fluorescence signal was gradually enhanced 
with the increasing of Au/Pt star@S-S@rHSA-FA@GOx 
concentration, revealing the obvious ROS could be generated by 
decomposing endogenous H2O2. Furthermore, the fluorescence 
value collected from flow cytometry could quantitatively validate 
above-mentioned results. As showed in Fig. 6B, the fluorescence 
value of green signal was proportional to the concentration of 
Au/Pt star@S-S@rHSA-FA@GOx, and increased to 2436 when 
the concentration of Au/Pt star@S-S@rHSA-FA@GOx reached to 
200 μg/mL, showing admirable peroxidase property of Au/Pt 
star@S-S@rHSA-FA@GOx in producing toxic ·OH after targeted 
enrichment at the tumor site.  
 Besides, the photo-induced PDT based on IR780 also played a 
crucial role in cancer therapy. To investigate intracellular ROS 
production of different materials under laser irradiation, the cells 
were firstly incubated with various materials at relatively safe 
concentrations. The cells were firstly incubated with PBS, free 
IR780 (3 μg/mL), Au/Pt star@S-S@rHSA-FA@GOx (15 μg/mL) 
and probes (18 μg/mL) in respective, and treated without or with 
irradiation, and finally stained by H2DCFDA dye. Here, the CLSM 
were carried out to study the ROS generation of various materials 
in cells. As shown in the CLSM images of Fig. 6C, no fluorescence 
signals were collected in PBS and IR780 groups when in dark, 
while slight fluorescence signals were showed in the Au/Pt 
star@S-S@rHSA-FA@GOx and probes groups in absence or 
presence of laser, suggesting the Au/Pt star in probes could be 
acted as peroxidase to catalyze the H2O2 and produced ·OH at both 
dark and irradiation. Notably, compared with other groups, obvious 
and strong green fluorescence could be observed in IR780 and 
probes under irradiation, indicating that IR780 could effectively 
generate ROS in the presence of laser irradiation. Moreover, the 
strongest fluorescence signal was collected from the probes group, 
revealing remarkable ROS generation efficacy based on IR780 and 
Au/Pt star of probes under irradiating.  
 
Fig. 6. Cellular ROS analysis: (A) Confocal images of Cells interacted with 
Au/Pt star@S-S@rHSA-FA@GOx at various concentration (0 to 200 μg/mL). 
scale bar: 100 μm. (B) Green fluorescence value at various concentration (0 to 
200 μg/mL) recorded by flow cytometry. (C) CLSM imaging of cells treated 
with various materials without irradiation (“dark”) or with irradiation (“laser”). 
scale bar: 100 μm. (Green signal: carboxy-H2DCFDA dye stained cell to reflect 
ROS generation) 



































































The tumor-targeting abilities of various materials have been 
investigated by tracking in vivo fluorescence images of free IR780 
and probes after tail vein injection into MGC803-tumor bearing 
mice, and free IR780 was acted as a control. As showed in Fig. 7A, 
free IR780 exhibited a relatively weak fluorescence intensity in 
tumor sites at different time, while obvious fluorescence signals 
were appeared in the tumor site of the probes treated mice, 
suggesting favorable tumor-targeting capabilities of constructed 
probes. In addition, more and more probes accumulated in the 
tumor tissue with prolonging the circulation time from 2 to 36 h, 
and still displayed remarkable signal after 48 h post-injection. 
However, in free IR780 group, there were gradually reducing red 
fluorescent signals in tumor site after 24 h post-injection, and 
displayed a weak tumor fluorescent signal in 48 h, suggesting that 
small IR780 molecules could be quickly excreted from body and 
slightly accumulated in tumor site. As shown in Fig. 7B, the 
fluorescence intensity value was quantitatively measured. The 
mean fluorescence value collected from probes group was stronger 
than that in free IR780 group at every time point, and reached 
maximal value at 36 h. Additionally, there was still strong intensity 
value even that the circulation time was up to 48 h. In contrast, the 
intensity values in free IR780 were low in all time points, and 
began to decrease at 36 h. All above-discussed results indicated 
that here prepared probes revealed good targeted accumulation and 
long retention time, endowing potentially effective therapy based 
on abundant probes.  
To investigate the body distribution of probes and IR780, organs 
and tumor were excised after 48 h post-injection and imaged on an 
optical imaging technique. As illustrated in Fig. 7C, there was 
weak fluorescence exhibited in the tumor of free IR780 treated 
mice while an obvious accumulation showed in the tumor region of 
probes treated mice, confirming above-acquired results in vivo 
tumor-targeted fluorescence imaging. Moreover, the result of 
coupled plasma mass spectrometry (ICP-MS) proved that some 
nanoprobes aggerated in tumor site and some organs (liver, spleen 
and lung) after 48 h treatment. The accumulation in liver, spleen 
and lung may cause by partial interception of reticuloendothelial 
system (data shown in Fig. S4) [17].     
 
Fig. 7. (A) Real-time fluorescence imaging of MGC803-tumor bearing mice 
intravenously injected with free IR780 and probes (Au/Pt 
star@S-S@rHSA-FA@IR780@GOx) at various time point from 2 h to 60 h 
(Parameters: excitation at 710 nm, emission at 790 nm, integration time in 60 s). 
(B) Fluorescence intensity in tumor region prolonging with time. (C) 
Fluorescence images of organs (heart, liver, spleen, lungs, and kidney) and 
tumors from free IR780 and probes treated mice after 48 h post-injection. 
3.9 The therapy effect of probes in Tumor-Bearing Mice 
Finally, the therapeutic effect of probes was studied by using 
MGC-803 tumor-bearing mice. Firstly, the mice were treated with 
PBS, free IR780, Au/Pt star@S-S@rHSA-FA@GOx or probes (1 
mg/kg of IR780, 5 mg/kg of Au/Pt star@S-S@rHSA-FA@GOx) in 
respective. After circulation for 36 h, the tumor region of mice was 
illuminated by 808 nm laser (1.0 W/cm2, 5 min), and the 
temperature fluctuation at tumor sites was monitored by a NIR 
camera. As illustrated in Fig. 8A, the temperatures were increased 
with prolonging of irradiation time within 5 min. Among various 
groups, after 5 min irradiation in 1.0 W/cm2, the temperatures in 
tumor of Au/Pt star@S-S@rHSA-FA@GOx, free IR780 and 
probes groups could reach to 47.9 °C, 49.7 °C and 56.1 °C 
respectively, showing the superior PTT therapy efficacy of probes 
due to the irreversible damage aroused by laser irradiation. 
However, the temperature in tumor site of PBS-treated mice was 
increased to 39.2 °C, proving safe irradiation power and time.  
Then tumor size change and the bodyweight fluctuation of 
various materials treated mice were recorded to exhibit the therapy 
effect. As showed in Fig. 8B, the PBS groups in dark and 
irradiation as well as the IR780 group in absence of irradiation 
showed the almost same growth rate of tumor and the relative 
tumor volume (V/V0) reached to the highest among all groups (V: 
real-time volume, V0: initial tumor volume). However, when the 
tumor of IR780 treated mice was irradiated, the tumor showed a 
relatively slow growth rate compared with the mice injected with 
IR780 in dark, showing good PPT and PDT of IR780. Moreover, 
compared with PBS group, we could observe that there were 
almost same and low tumor increasing rate appeared in the groups 
including Au/Pt star@S-S@rHSA-FA@GOx and probes without 
irradiation, indicating potentially excellent cancer starvation 
therapy and enzymes oxidative therapy based on consuming 
glucose by GOx and generating ·OH by the reaction between Au/Pt 
star and H2O2. Due to the NIR-resonant property of Au/Pt star, the 
Au/Pt star@S-S@rHSA-FA@GOx could produce heat to damage 
the tumor after absorbing NIR light, and therefore the Au/Pt 
star@S-S@rHSA-FA@GOx presented a lower growth rate when 
irradiating, proving excellent PTT effect of Au/Pt star. 
Undoubtedly, owing to collaborative therapy effects of IR780, 
Au/Pt star and GOx, probes displayed excellent tumor growth 
inhibition within 15 days.  
To monitor the therapy-induced adverse collateral effect based on 
synthesized probes, the weight of various materials treated mice 
were recorded. As exhibited in the Fig. 8C, there was almost no 
obvious weight loss of the mice during the therapy process, 
indicating the favorable biocompatibility and biosafety of probes. 
Moreover, the tumor change during therapy process was imaged by 
a camera. As shown in the Fig. S5, the tumors from the mice 
treated with PBS under dark or laser irradiation and the tumor in 
IR780 under dark showed obvious growth tendency prolonged with 
time. And, tumors from the mice injected with Au/Pt 
star@S-S@rHSA-FA@GOx and probes under dark exhibited a 
slower growth rate compared with PBS group due to the enzyme 


































































PTT&PDT property of IR780 and Au/Pt star, the tumor in groups 
contained the IR780 under irradiation, Au/Pt 
star@S-S@rHSA-FA@GOx under irradiation and probes under 
irradiation all showed better inhibition tendency than those groups 
without irradiating. Notably, the tumor of probes (Au/Pt 
star@S-S@rHSA-FA@GOx@IR780) treated mice showed an 
atrophied trend, in which obvious scar appeared after 4 days, tumor 
ablated and normal tissue regenerated after 15 days. After 30 days, 
no new tumor tissue regenerated (showed in Fig. S6), indicating 
the favorable therapy effect of constructed Au/Pt 
star@S-S@rHSA-FA@IR780@GOx probes.  
In addition, the organs (heart, liver, spleen, lung and kidney) of 
probes treated mice were stained by H&E dye to investigate 
histopathological examination. As showed in Fig. 8D, there was no 
noticeable sign of pathological damage appeared in the main 
organs, further suggesting good biocompatibility of probes in mice.  
 
Fig. 8. (A) Infrared thermal imaging of mice injected with PBS, free IR780, 
Au/Pt star@S-S@rHSA-FA@GOx and Au/Pt 
star@S-S@rHSA-FA@IR780@GOx (1 mg/kg of IR780, 5 mg/kg of Au/Pt 
star@S-S@rHSA-FA@GOx) to study the tumor temperature change prolonging 
with irradiation time (1.0 W/cm2, 808 nm). (B) Relative tumor volume variation 
in different materials treated mice with or without lasering. (n=5, *P < 0.05, **P 
< 0.01). (C) Body weight change of various materials treated mice with or 
without lasering. (D) H&E study of main organs from PBS and probes treated 
mice after 15 days. Scale bar: 100 μm. 
4 Conclusions 
In this work, we introduced multifunctional probes (Au/Pt 
star@S-S@rHSA-FA@IR780@GOx) used for gastric cancer 
diagnosis and therapy, which possessed excellent targeted effect, 
real-time imaging, favorable GSH-responsive property and 
prominent therapy effect combining glucose starving-like 
therapy/enzyme oxidative therapy/PTT/PDT. Interesting, as the 
constructed probes were specifically targeted to the tumor sites, 
sequential reactions including GSH-sensitive IR780 releasing, 
nutrients (glucose and O2) depletion by GOx to generate H2O2 and 
enhance acidity, Fenton-like reaction between Pt nanolayer and 
H2O2 to produce toxic ·OH, and IR780 induced PTT/PDT under 
808 nm irradiation would occur, achieving prominent theragnostic 
with real-time imaging and synergetic cancer starving-like 
therapy/enzyme oxidative therapy/PTT/PDT feature. In the result, 
the tumor was ablated and without regeneration after 30 days. All 
above-demonstrated results suggested that our preliminary work 
provided an eminent strategy for tumor theragnostic by using the 
specific tumor environment and assembling cancer 
starvation/enzyme catalysis/PTT&PDT treatment 
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1. In this work, we have successfully prepared a sequential catalytic platform based on Au/Pt star 
for tumor theragnostic by using unique tumor microenvironment.  
2. Here we demonstrated that our probes simultaneously possessed a GSH-sensitive release, real-
time imaging ability, and synergetic cancer starving-like therapy/nanozyme oxidative therapy/PTT/PDT 
features, which provides a potential strategy for effective tumor theragnostic. 
 
 
